Skip to main content

Table 4 New broncho-pulmonary colonization and antibiotic courses of pediatric cases and age-matched controls during the year after A/H1N1 2009 pandemic influenza

From: Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy

 

n

Cases (n = 33)

n

Controls (n = 55)

p

Age

33

9.7+/- 4.7

55

9.5+/- 4.8

0,9

Antibiotics, number of treatments, mean (SD)

   

 Oral

33

2.7 (2.2)

55

2.4 (2.6)

0.40

 Intravenous

33

0.52 (1.12)

55

0.56 (2.01)

0.33

New bronchopulmonary colonization, n (%)

   

 Any germ

33

13 (39)

55

26 (47)

0.47

H. influenza

33

1 (3)

55

9 (16)

0.04

S. aureus

33

3 (9)

55

6 (11)

0.78

P. aeruginosa

33

6 (18)

55

6 (11)

0.44

B. cepacia

33

0

55

1 (2)

0.40

A. fumigatus

33

3 (9)

55

4 (7)

0.94

Oxygen therapy, n (%)

33

0 (0)

55

0 (0)

1

Noninvasive ventilation, n (%)

33

0 (0)

55

0 (0)

1

  1. Both are compared to reference data and expressed as percent predicted values, based on age, gender, and height
  2. FEV1 forced expiratory volume in one second, FVC forced vital capacity, SD standard deviation